Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy.

× No keyword cloud information.

24 in total

Review 1. Cutaneous toxicities of new treatments for melanoma.

Authors: A Boada; C Carrera; S Segura; H Collgros; P Pasquali; D Bodet; S Puig; J Malvehy
Journal: Clin Transl Oncol Date: 2018-05-24 Impact factor: 3.405

2. Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib.

Authors: David A Liebner; Steven A Walston; Robert Cavaliere; Ciaran J Powers; Eric Sauvageau; Norman L Lehman; Hasel Wayne Slone; Meng Xu-Welliver; Fen Xia; Kari L Kendra
Journal: Melanoma Res Date: 2014-04 Impact factor: 3.599

3. A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERT.

Authors: Gregory A Hosler; Teresa Davoli; Ilgen Mender; Brandon Litzner; Jaehyuk Choi; Payal Kapur; Jerry W Shay; Richard C Wang
Journal: J Cutan Pathol Date: 2014-12-11 Impact factor: 1.587

Review 4. Managing the skin toxicities from new melanoma drugs.

Authors: John C Mavropoulos; Timothy S Wang
Journal: Curr Treat Options Oncol Date: 2014-06

Review 5. [Cutaneous side effects of targeted cancer drugs].

Authors: J Below; B Homey; P A Gerber
Journal: Hautarzt Date: 2017-01 Impact factor: 0.751

Review 6. Interaction of radiation therapy with molecular targeted agents.

Authors: Zachary S Morris; Paul M Harari
Journal: J Clin Oncol Date: 2014-08-11 Impact factor: 44.544

7. [Cutaneous side effects of anti-tumor therapy with BRAF and MEK inhibitors].

Authors: R Gutzmer; J C Hassel; K C Kähler; C Loquai; R Mössner; S Ugurel; L Zimmer; Für Komitee Kutane Nebenwirkungen Ado der das Ado
Journal: Hautarzt Date: 2014-07 Impact factor: 0.751

Review 8. Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship.

Authors: Colette J Shen; Michael Lim; Lawrence R Kleinberg
Journal: Curr Treat Options Oncol Date: 2016-09

Review 9. Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG).

Authors: Christopher J Anker; Kenneth F Grossmann; Michael B Atkins; Gita Suneja; Ahmad A Tarhini; John M Kirkwood
Journal: Int J Radiat Oncol Biol Phys Date: 2016-06-01 Impact factor: 7.038

10. Unusual acute and delayed skin reactions during and after whole-brain radiotherapy in combination with the BRAF inhibitor vemurafenib. Two case reports.

Authors: B Schulze; M Meissner; M Wolter; C Rödel; C Weiss
Journal: Strahlenther Onkol Date: 2013-12-22 Impact factor: 3.621